UNSPSC 51284303: Thiamphenicol

This classification denotes a protein synthesis inhibitor and antibiotic with the molecular formula C12H15Cl2NO5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FLQ7571NPM, chemically known as (+-)-threo-2,2-dichloro-n-(beta-hydroxy-alpha-(hydroxymethyl)-p-(methylsulfonyl)phenethyl)acetamide but generally known as thiamphenicol, which bears US NIH Compound Identifier 5433. European Medicines Agency schedules Thiamphenicol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10970MIG.

UNSPSC 51284303 Thiamphenicol, a Commodity code, shows minimal recent state and local procurement activity aligned with its nominal scope. The two recent opportunities tagged to this code involve pharmaceutical procurement—a piggyback contract through MMCAP Infuse for Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets, and a Seminole County, Florida IFB for Naloxone and drug deactivation systems—but neither solicitation directly addresses thiamphenicol supply. State and local procurement under this code appears sparse or misaligned with the taxonomy classification, limiting current visibility into active demand for thiamphenicol itself.

The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through MMCAP Infuse to Chartwell Rx LLC in August 2026 under an Invitation for Bid process, while Seminole County posted an IFB on June 30, 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries. These two opportunities represent the recent activity visible under the code, but neither reflects the specific pharmaceutical product (thiamphenicol) the code nominally covers. Procurement activity under this code does not currently show a clear pattern of state or local demand for thiamphenicol as a standalone commodity.